UC Davis Health is unveiling two brand-new initiatives — the Health Venture Studio and the Investing in the Future of Medicine (IFM) Fund — to more quickly translate university research into real-world solutions that improve human health. Both initiatives are based at Aggie Square, the university’s innovation district in Sacramento, and are led by UC Davis Health Ventures, the university’s commercialization and venture-building arm focused on advancing human health innovation.
As its first phase opens in May 2025, Aggie Square represents a transformative convergence of UC Davis’ scientific, clinical and entrepreneurial strengths with private-sector collaboration. When fully developed, the district is projected to generate more than $500 million annually in regional economic output and support over 3,000 new jobs, driving inclusive growth and innovation across the Sacramento region.
The Health Venture Studio at Aggie Square identifies and advances promising UC Davis interdisciplinary research innovations in therapeutics, digital health, molecular diagnostics and medical devices. Through continued development and validation within the university, these technologies are better positioned for clinical and financial impact when licensed or launched as startups.
The IFM Fund, a $25 million investment initiative, complements the studio by directly funding cutting-edge research and the incubation of startups emerging from UC Davis, as well as investing in high-potential companies from outside the university that align with its mission.
